|
CDKN2AIP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.1094237467878E-14 |
| Normal-vs-Stage2 |
1.68300000047417E-07 |
| Normal-vs-Stage3 |
9.30366894635881E-14 |
| Normal-vs-Stage4 |
1.8069989948799E-12 |
| Stage1-vs-Stage2 |
9.458400E-01 |
| Stage1-vs-Stage3 |
9.397700E-02 |
| Stage1-vs-Stage4 |
1.918290E-02 |
| Stage2-vs-Stage3 |
2.631600E-01 |
| Stage2-vs-Stage4 |
7.433800E-02 |
| Stage3-vs-Stage4 |
3.446400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.579480E-04 |
| Normal-vs-Asian |
1.63332999999488E-05 |
| Caucasian-vs-AfricanAmerican |
1.287990E-01 |
| Caucasian-vs-Asian |
2.532100E-02 |
| AfricanAmerican-vs-Asian |
8.837600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.33670852164869E-13 |
| Normal-vs-Female |
1.62492241884138E-12 |
| Male-vs-Female |
9.239000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.15794049296392E-12 |
| Normal-vs-Age(41-60Yrs) |
3.46389583683049E-14 |
| Normal-vs-Age(61-80Yrs) |
2.46846987295157E-12 |
| Normal-vs-Age(81-100Yrs) |
1.402560E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.318800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.842840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.509400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.150200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.896400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.598800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.918300E-02 |
| Classical-VS-Follicular |
6.244000E-02 |
| Classical-VS-Other |
9.561400E-01 |
| Classical-VS-Normal |
1.66400226930818E-12 |
| Tall-VS-Follicular |
7.332600E-01 |
| Tall-VS-Other |
5.056400E-01 |
| Tall-VS-Normal |
5.48250334020395E-11 |
| Follicular-VS-Other |
5.310200E-01 |
| Follicular-VS-Normal |
2.11930473170696E-11 |
| Other-VS-Normal |
1.192490E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.27515792264421E-14 |
| Normal-vs-N1 |
2.57038834661216E-12 |
| N0-vs-N1 |
9.150300E-02 |
|
|
